However, SCGB2A2 sensitivity is limited particularly for detecting triple-negative breast cancer; moreover, it has been reported to be present in female reproductive tract tumors such as cervix, endometrium, ovary as well as certain salivary gland tumors and skin cancer. Here, SCGB2A2 is linked to tumor of salivary gland.